Well help you find the right path to a sustainable weight based on your health history, body type, and lifestyle
Perrone A, Giovino A, Benny J, Martinelli F (2020) Advanced glycation end products (AGEs): biochemistry, signaling, analytical methods, and epigenetic effects
June 26th, 2024: Study reveals GLP-1 drugs may cause bone density loss without exercise A recent study from the University of Copenhagen raises new concerns about GLP-1 medications, including Ozempic, Wegovy, and Mounjaro, highlighting potential bone density loss
Research interest centered around metabolic efficiency and appetite-related signaling pathways
For example, our NMN + Trans-Resveratrol formula supports NAD+ levels, which are also vital for cellular energy and are depleted by alcohol